Schaub M - Search Results

1

Cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers?

Schaub M, Fanghaenel K, Senn C, Stohler R. Schaub M, et al. Subst Use Misuse. 2008 Dec;43(14):2045-52. doi: 10.1080/10826080802587298. Subst Use Misuse. 2008. PMID: 19085437

2

[Cannabis and psychosis--a review].

Schaub M, Rössler W, Stohler R. Schaub M, et al. Praxis (Bern 1994). 2004 Jun 2;93(23):997-1002. doi: 10.1024/0369-8394.93.23.997. Praxis (Bern 1994). 2004. PMID: 15233568 Review. German.

3

[For and against: cannabis].

Schaub M, Dürsteler-MacFarland K, Stohler R, Thomasius R. Schaub M, et al. Psychiatr Prax. 2005 Mar;32(2):58-61. doi: 10.1055/s-2004-834651. Psychiatr Prax. 2005. PMID: 15712036 German. No abstract available.

4

Association between aggressiveness, schizotypal personality traits and cannabis use in Swiss psychology students.

Schaub M, Boesch L, Stohler R. Schaub M, et al. Psychiatry Res. 2006 Aug 30;143(2-3):299-301. doi: 10.1016/j.psychres.2005.07.034. Epub 2006 Jun 27. Psychiatry Res. 2006. PMID: 16806489

5

[Club drugs].

Senn Ch, Bücheli A, Schaub M, Stohler R. Senn Ch, et al. Among authors: schaub m. Ther Umsch. 2007 Feb;64(2):109-13. doi: 10.1024/0040-5930.64.2.109. Ther Umsch. 2007. PMID: 17245678 Review. German.

6

The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients.

Wapf V, Schaub M, Klaeusler B, Boesch L, Stohler R, Eich D. Wapf V, et al. Among authors: schaub m. Harm Reduct J. 2008 Mar 18;5:10. doi: 10.1186/1477-7517-5-10. Harm Reduct J. 2008. PMID: 18348722 Free PMC article.

7

Reasons for cannabis use: patients with schizophrenia versus matched healthy controls.

Schaub M, Fanghaenel K, Stohler R. Schaub M, et al. Aust N Z J Psychiatry. 2008 Dec;42(12):1060-5. doi: 10.1080/00048670802512016. Aust N Z J Psychiatry. 2008. PMID: 19016094

8

Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophrenia.

Buadze A, Stohler R, Schulze B, Schaub M, Liebrenz M. Buadze A, et al. Among authors: schaub m. Harm Reduct J. 2010 Sep 28;7:22. doi: 10.1186/1477-7517-7-22. Harm Reduct J. 2010. PMID: 20920183 Free PMC article.

9

Leisure time activities that predict initiation, progression and reduction of cannabis use: a prospective, population-based panel survey.

Schaub M, Gmel G, Annaheim B, Mueller M, Schwappach D. Schaub M, et al. Drug Alcohol Rev. 2010 Jul;29(4):378-84. doi: 10.1111/j.1465-3362.2009.00156.x. Drug Alcohol Rev. 2010. PMID: 20636653

10

Development of an integrative cessation program for co-smokers of cigarettes and cannabis: demand analysis, program description, and acceptability.

Becker J, Hungerbuehler I, Berg O, Szamrovicz M, Haubensack A, Kormann A, Schaub MP. Becker J, et al. Among authors: schaub mp. Subst Abuse Treat Prev Policy. 2013 Sep 12;8:33. doi: 10.1186/1747-597X-8-33. Subst Abuse Treat Prev Policy. 2013. PMID: 24025478 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

509 results

Search Page